Firm News: Drugs & Devices: Page 14

W&L’s Paul Pennock was one of two court-appointed lead counsel on the Plaintiffs Steering Committee for the multidistrict litigation against drug manufacturer Takeda.

A recent voluntary recall of the porous coated, uncemented Zimmer Persona Knee Trabecular Metal Tibial Plates, which the U.S. Food and Drug Administration (FDA) subsequently categorized as a Class II recall, has led Weitz & Luxenberg, P.C., to begin accepting cases involving Zimmer Persona Knee replacement injuries, the law firm today announced. The company that…

Weitz & Luxenberg is now investigating cases in which patients suffered harm from use of a Zimmer Persona knee replacement device. The porous coated, uncemented Zimmer Persona Trabecular Metal Tibial Plate was voluntarily recalled on Feb. 16 and was categorized as a U.S. Food and Drug Administration (FDA) Class II recall on March 12. The…

Expanding news coverage of the cancer-spread risks posed by power morcellators is helping show why women are right to seek compensation from the makers of the surgical devices, Weitz & Luxenberg said.   The most recent reports of injuries to women appeared in The Wall Street Journal, which in late November ran two major stories…

Stryker Corp. has agreed to pay potentially more than $1 billion to settle claims from patients injured by the company’s Rejuvenate and ABGII modular hip implants, the nationally prominent personal-injury law firm of Weitz & Luxenberg today announced. The settlement capped nearly four months of intensive negotiations between Stryker and Weitz & Luxenberg’s Ellen Relkin…